Igor V Ermakov

Title: Igor V Ermakov: Innovator in Noninvasive Measurement Technologies

Introduction

Igor V Ermakov is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of noninvasive measurement technologies, particularly in the assessment of flavonoid and carotenoid compounds in biological tissues. With a total of two patents to his name, Ermakov's work has the potential to impact medical diagnostics and health monitoring.

Latest Patents

Ermakov's latest patents include innovative methods and apparatuses for the noninvasive measurement of flavonoid compounds in biological tissue. These methods facilitate rapid and quantitative measurement of flavonoid concentrations, including their isomers and metabolites, in human skin. By utilizing low-intensity, visible-light illumination, the technology achieves high spatial resolution, allowing for precise quantification of flavonoid levels. The system comprises a light source for illuminating tissue, a device for detecting emitted fluorescence, and a processor for determining the concentration of flavonoids based on the detected fluorescence.

Another significant patent focuses on the noninvasive measurement of carotenoids in biological tissue. This method provides a rapid, accurate, and safe determination of carotenoid levels, which can offer diagnostic insights into the antioxidant status of tissue. The technique employs reflection spectroscopy to measure carotenoid concentrations, utilizing white light directed at the tissue of interest. The method allows for real-time monitoring and analysis of the reflection spectrum, minimizing the influence of hemoglobin and oxyhemoglobin absorptions.

Career Highlights

Ermakov's career is marked by his dedication to advancing noninvasive measurement techniques. His work at Longevity Link Corporation has positioned him as a leader in the field, contributing to innovative solutions that enhance diagnostic capabilities. His patents reflect a commitment to improving health monitoring through technology.

Collaborations

Ermakov has collaborated with notable colleagues, including Werner Gellerman and Mohsen Sharifzadeh. These partnerships have fostered a collaborative environment that encourages innovation and the development of cutting-edge technologies.

Conclusion

Igor V Ermakov's contributions to noninvasive measurement technologies exemplify the intersection of innovation and health science. His patents not only advance the field but also hold promise for future applications in medical diagnostics.